FDA Approves ZOLADEX — TerSera Therapeutics LLC

# FDA Drug Approval: TerSera Therapeutics' ZOLADEX TerSera Therapeutics LLC received FDA approval for ZOLADEX (goserelin acetate), a subcutaneous gonadotropin-releasing hormone agonist indicated for hormone-sensitive cancers and endometriosis, positioning the company in the oncology and women's health markets. The approval establishes TerSera's foothold in a significant therapeutic area with sustained revenue potential from chronic treatment regimens.